Skip to main content
. 2024 Jul 3;38(4):1891–1899. doi: 10.21873/invivo.13644

Table I. Clinicopathological characteristics of patients (n=53).

graphic file with name in_vivo-38-1893-i0001.jpg

ECOG PS: Eastern Cooperative Oncology Group performance status; EGFR: epidermal growth factor receptor; PD-1: programmed cell death 1; PD-L1: programmed cell death 1 ligand; VEGFR: vascular endothelial growth factor receptor. aEsophagus (2 patients) and maxilla (1 patient). bDiagnosis confirmed at another hospital. *American Joint Committee on Cancer 8th edition.